Bezirgiannidou, Zoe
Stamatiou, Iliana
Theodoridis, Theodoros M.
Kontekaki, Eftychia
Panagiotopoulos, Emmanouil
Misidou, Christina
Vrachiolias, George
Malkots, Bouse
Papoutselis, Menelaos
Kotsianidis, Ioannis
Spanoudakis, Emmanouil
Liapis, Konstantinos
Funding for this research was provided by:
Democritus University of Thrace
Article History
Received: 30 December 2024
Accepted: 16 August 2025
First Online: 28 August 2025
Declarations
:
: The authors declare no competing interests.
: The patient has provided written informed consent.
: The use of ravulizumab in this case was approved by the Ethics Committee of the Hospital (Protocol: No. 4/31/795).
: All authors declare no competing interests.